Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board granted service connection for acne keloidalis and unspecified depressive disorder with anxiety, effective from the period of active duty.

The Board denied increased ratings for PTSD, TBI, migraine headaches, asthma, lumbosacral strain, right leg stress fracture of tibia with shin splints and LCL sprain, and dyshidrotic eczema. However, it granted a 50 percent rating for migraines since April 13, 2021, an earlier effective date of May 6, 2020, but no earlier, for the 70 percent rating of PTSD; an earlier effective date of April 13, 2021, but no earlier, for the grant of service connection for TBI and the 50 percent rating of migraine headaches; and an earlier effective date of May 20, 2022, but no earlier, for the 30 percent rating of asthma.

The Board remands the issue of service connection for a chronic skin condition, to include dermatitis herpetiformis, folliculitis, and eczema, as an addendum opinion is needed regarding the nature and etiology of any chronic skin condition.

The Board granted service connection for dyshidrotic eczema skin rash, which is presumptively related to the Veteran's service in Southwest Asia.

The Board denied a compensable rating for pseudofolliculitis barbae and remanded service connection claims for hypertension and low back disability.

The Board denied the veteran's claim for service connection for bilateral hearing loss as there was no current diagnosis of a disability for VA purposes. The claims for an acquired psychiatric disorder and athlete's foot were remanded for further development.

The Board remands the claim for a more adequate VA examination to address direct service connection and other potential theories of entitlement.

The Board denied an earlier effective date for a 100 percent rating for PTSD and DEA benefits, but granted the reinstatement of a 10 percent rating for eczema.

The appeal for an effective date prior to October 23, 2017, for the award of service connection for PTSD with major depressive disorder, alcohol use disorder, and TBI residuals; tinnitus, and a rating in excess of 10 percent for tinnitus was dismissed. The appeal for service connection for bilateral hearing loss was denied.

The Board allowed a 20-percent evaluation for bilateral tinea pedis, an earlier effective date was denied for service connection for tinnitus, and a 100-percent evaluation was granted from July 16, 2018, for adjustment disorder with mixed anxiety and a depressed mood.

The Veteran withdrew the appeals for service connection and initial rating, resulting in their dismissal.

The Board granted service connection for otitis media of the right ear with conductive hearing loss and denied increased ratings for tinnitus and eczema.

The Board granted a 10 percent rating for chronic sinusitis and denied service connection for eczema.

The Board denied service connection for acne, a bladder disorder, and a headache disorder as they are not shown to be causally or etiologically related to any disease, injury, or incident during the Veteran's military service.

The Board denied higher ratings for PTSD and alcohol and cannabis use disorder but granted a 10% rating for seborrheic dermatitis from August 9, 2018 to May 25, 2021.

The Board granted service connection for chloracne, finding that the Veteran's exposure to herbicide agents during his military service in Vietnam caused the condition.

The Board denied the veteran's claims for an initial compensable disability rating for dermatitis and service connection for posttraumatic stress disorder, anxiety condition, and obstructive sleep apnea.

The Board granted service connection for pseudofolliculitis barbae and remanded several other claims, including diabetes, urinary disorder, bilateral hearing loss, back disability, traumatic brain injury (TBI), neurological disorder, left shoulder disability, neck disability, and tinnitus.

The Board granted service connection for trochanteric pain syndrome of bilateral hips, bilateral ankle sprain, and patellofemoral pain syndrome of bilateral knees. The remaining claims were denied.

The Veteran was granted an initial rating of 20 percent for neoplasm of the kidney, but no higher. The claim for a higher initial rating for eczema was denied.